RT Journal Article
SR Electronic
T1 Results of the Atlas Study
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 539
OP 542
VO 65
IS 10
A1 Hobbs, Robert E.
YR 1998
UL http://www.ccjm.org/content/65/10/539.abstract
AB In a large, randomized study, patients with heart failure who received a large daily dose of an angiotensin-converting inhibitor had a trend toward a lower mortality rate than did patients who received a low daily dose. Moreover, the hospitalization rate was lower in the high-dose group, and the side-effect profile was the same in both groups. Physicians should try to give maximal closes to achieve optimum benefit in this patient population.